Wednesday, 15 November 2017

Soft Mist Inhalers - A Perfect Remedy for Chronic Diseases

Increase of pollution and various irritants in the air has gradually increased the possibility of chronic diseases such in the human beings. These diseases are non-curable and require extra precautions through a lifetime. Patients suffering from such diseases as face major respiratory issues, which can be controlled by using soft mist inhalers.

Read full research report at :

Growing Health Awareness to Promote Sales of Inhalers

The major product-variants of soft mist inhaler are asthma and Chronic Obstructive Pulmonary Disease (COPD). Continuous exposure to various irritants and substances which could trigger allergies can contribute to the growth of asthma symptoms in humans. Increase in the number of patients suffering from asthma propels the demand for inhalers. To cater to the inflating demand of asthma inhalers, most manufacturing companies are doing R&D to develop products which are better and innovative. For instance, two Georgian entrepreneurs Bacho Khachidze and Lasha Kvantaliani have invented a device named Treepex. The device can transform polluted air into fresh oxygen.

Moreover, COPD inhalers are also playing a significant role in the growth of this market. Though patent expiry of drugs being used in the inhalers and government regulations are obstructing the market growth. Yet, there are few public and private organizations contributing through some supporting initiatives to alleviate the sufferings from respiratory diseases. By spreading health awareness and improving the respiratory care globally, these organizations have fairly contributing to the market growth.

Market Insights

Increase in global ageing population and prevalence of chronic diseases such as asthma and COPD may propel the soft mist inhalers market. In addition, excess of cigarette smoking and increasing air pollution are also contributing to respiratory issues growing in humans. Considering these facts, most manufacturing companies are continuously working on product development. The initiatives being taken by the government and non-government organizations to spread health awareness can augment the growth of the market at a phenomenal CAGR during the forecast period (2012 to 2022), according to a report on Radiant Insights, Inc.

Some of the key players contributing the market are Respimat, AstraZeneca PLC, Propeller Health, Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim GmbH

To get free sample request at :

No comments:

Post a Comment